Research Article | Open Access
EFFICACY AND SAFETY OF THE DEVELOPED NANOPARTICLES FOR THE TREATMENT OF RETINAL DEGENERATION
Dr. NARDEV SINGH
Pages: 697-707
Abstract
The advancement of medicine has entered a new phase because to the study of nanoparticles (NPs). Nanoparticles (NPs) are tiny particles, on the scale of cells and molecules, with a size between 10 and 1,000 nm. NPs have the potential to transport pharmaceuticals to bypass barriers, drug targeting, drug sustained release, medication safety, and even gene therapy, making them an attractive alternative to conventional ophthalmic treatments. After a quick overview of NP categorization, we will propose novel approaches developed from NPs with the aim of improving the diagnosis and treatment of a variety of retinal illnesses.
Keywords
Nanomaterials, retina, gene therapy, drug delivery